E-Posters-Efficacy and Safety of Hybrid Fractional Laser (1470nm and 2940nm) for Objective Female Stress Urinary Symptoms: 6 Month Interim Analysis in a Prospective Multi-Center Study

Efficacy and Safety of Hybrid Fractional Laser (1470nm and 2940nm) for Objective Female Stress Urinary Symptoms: 6 Month Interim Analysis in a Prospective Multi-Center Study - Michael J. Kennelly, MD

Back to course

Pdf Summary

A study was conducted to evaluate the safety and efficacy of dual energy Hybrid Fractional therapy in women with stress predominant urinary incontinence (UI) symptoms. The therapy involved using a laser to stimulate tissue remodeling in the vagina. The study included 51 patients aged 30-75 years who underwent three laser treatments at four-week intervals. The treatments were well tolerated, with a median pain score of 3 out of 10. No adverse events were reported. <br /><br />After the treatments, 67.5% of patients reported improvement in symptoms, and 71% expressed satisfaction with the treatment. Histological findings showed an increase in epithelial thickness at 3 and 6 months post-treatment. Objective measures, such as cough stress test and urogenital distress inventory, showed improvements in stress urinary incontinence. <br /><br />The study concluded that Hybrid Fractional Laser diVa is a safe and effective treatment for urinary incontinence symptoms with minimal discomfort and no adverse events. Follow-up data collection is ongoing for a 12-month period.

Keywords

dual energy Hybrid Fractional therapy

stress urinary incontinence

laser treatments

safety

efficacy

pain score

adverse events

improvement

histological findings

follow-up data collection